Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Knowing where to invest for retirement in your 40s is essential. Uncover top investment opportunities that align with your goals.
17,541 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
A Florida man allegedly used manipulated video game installers to spread malware, siphoning crypto from victims. The ...
When a CFO sells a notable chunk of stock, investors want clarity. This article breaks down what CoreWeave's sold com...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
DraftKings posted strong top-line growth yet issued cautious guidance, sending its stock lower. This analysis breaks ...
A specialized REIT with cannabis-related tenants moved higher in today’s session. This article breaks down the factor...
February delivered a sharp setback for AMZN as investors weighed another wave of capital spending against growth pros...
As Ranpak tackles 2025 earnings, investors watch for sustainable packaging demand, margin discipline, and cash flow r...
Fastly stock already doubled this year, leaving many investors wondering if the rally can continue. This guide breaks...
Broadcom’s AI demand story is stirring a lot of chatter in markets. This article breaks down what the CEO’s remarks c...
As AI brings new pricing for memory, Micron stands at the crossroads of momentum and valuation. This guide breaks dow...
A headline about Palantir and a high-stakes defense AI plan could reshape risk and opportunity. This guide breaks dow...